OpGen gains as unit launches new genome sequencing services

CapForce

20/04/2022 16:43

** Shares of diagnostic company  OPGN.O  up 5% at 64 cents
    ** OPGN says its subsidiary, Ares Genetics is commercially
launching a series of new genome sequencing and analysis
services globally  urn:newsml:reuters.com:*:nGNX8qcy11
    ** Says its new services will enable detection and
surveillance of bacterial and fungal microbes and provide
outbreak relevant information such as on pathogen identity and
type
    ** The World Health Organization has stressed https://bit.ly/3vu9Uid
 on the importance of genomic surveillance for pandemic and
epidemic preparedness and response 
    ** Stock down 36% YTD

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))